Novartis OTC Division Is “Fastest Growing” Among Industry Leaders – CEO
This article was originally published in The Tan Sheet
Executive Summary
Novartis Consumer Health showed "strong performance" in 2006 with full year net sales of $7.53 billion, according to earnings results announced during a fourth-quarter and year-end call Jan. 18
You may also be interested in...
Novartis Cough/Cold OTCs Boost Consumer Health Division In Q1
Novartis' over-the-counter sales achieved double-digit growth in its first quarter on the strength of cough and cold brands and expansion into new markets, particularly Japan, the company said
Nestle Looks To Cook Up Nutrition Product Sales With Novartis MN Acquisition
Nestle looks to become the number two company in the healthcare nutrition field, including the infant formula market, with its planned $2.5 bil. acquisition of Novartis' Medical Nutrition unit
Novartis Sees OTCs As Crucial In Emerging – And Emerged – Global Markets
Over-the-counter and generic drugs will benefit "disproportionately" compared with prescription drugs in emerging global markets, according to Novartis Head of Corporate Mergers & Acquisitions Nayan Gregory Parekh, PhD